1. Home
  2. KBH vs KRYS Comparison

KBH vs KRYS Comparison

Compare KBH & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KBH
  • KRYS
  • Stock Information
  • Founded
  • KBH 1957
  • KRYS 2015
  • Country
  • KBH United States
  • KRYS United States
  • Employees
  • KBH N/A
  • KRYS N/A
  • Industry
  • KBH Homebuilding
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KBH Consumer Discretionary
  • KRYS Health Care
  • Exchange
  • KBH Nasdaq
  • KRYS Nasdaq
  • Market Cap
  • KBH 4.1B
  • KRYS 4.3B
  • IPO Year
  • KBH 1987
  • KRYS 2017
  • Fundamental
  • Price
  • KBH $64.76
  • KRYS $150.49
  • Analyst Decision
  • KBH Buy
  • KRYS Strong Buy
  • Analyst Count
  • KBH 12
  • KRYS 10
  • Target Price
  • KBH $67.04
  • KRYS $204.90
  • AVG Volume (30 Days)
  • KBH 1.4M
  • KRYS 422.6K
  • Earning Date
  • KBH 09-23-2025
  • KRYS 08-04-2025
  • Dividend Yield
  • KBH 1.54%
  • KRYS N/A
  • EPS Growth
  • KBH 0.49
  • KRYS 36.22
  • EPS
  • KBH 7.59
  • KRYS 4.91
  • Revenue
  • KBH $6,673,869,000.00
  • KRYS $359,205,000.00
  • Revenue This Year
  • KBH N/A
  • KRYS $34.33
  • Revenue Next Year
  • KBH N/A
  • KRYS $47.84
  • P/E Ratio
  • KBH $8.53
  • KRYS $30.77
  • Revenue Growth
  • KBH 3.65
  • KRYS 116.08
  • 52 Week Low
  • KBH $48.90
  • KRYS $122.80
  • 52 Week High
  • KBH $89.70
  • KRYS $207.84
  • Technical
  • Relative Strength Index (RSI)
  • KBH 65.51
  • KRYS 56.41
  • Support Level
  • KBH $59.60
  • KRYS $142.51
  • Resistance Level
  • KBH $64.00
  • KRYS $147.58
  • Average True Range (ATR)
  • KBH 1.99
  • KRYS 4.78
  • MACD
  • KBH 0.15
  • KRYS 0.39
  • Stochastic Oscillator
  • KBH 91.28
  • KRYS 92.81

About KBH KB Home

KB Home is an American construction company that focuses on residential construction in the United States. The company builds single-family homes and communities across different geographical segments which include the West Coast which also derives the majority of the revenue, Southwest, Central, and Southeast. The company operates in several markets and focuses on first-time and move-up homebuyers. It also invests in land acquisition and development to support future building activities and is also engaged in financial services operations which includes providing mortgage banking services through its joint venture with a third party.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: